(800) 369-0899
(215) 569-4000

Contact Us Today



← Older posts Newer posts →

New Report May Fuel Debate on Surgery

Mesothelioma is a deadly type of cancer that affects the lining, or pleura of the lung. When the cancer is diagnosed in its early stages, many patients who are in otherwise good health may be offered lung surgery as an option to improve their longevity and quality of life. The two most common surgeries have » Read More

Misconceptions Regarding Asbestos Exposure in the U.S.

This year marks the 40th Anniversary of the banning of asbestos fibers in fireplaces and wall patching compounds by the Consumer Product Safety Commission (CPSC). Just four years earlier, the Environmental Protection Agency (EPA) had banned the spray application of the same. Twelve years after the CPSC ban, the EPA went further and banned many » Read More

Philadelphia Mesothelioma Lawyers: Important Update on Keytruda

Pembrolizumab, a drug that helps destroy cancer cells by working with the immune system, has been fully approved by the United States Food and Drug Administration (FDA). This is very good news for mesothelioma patients because clinical trials of the immunotherapy drug, marketed as Keytruda by Merck & Company, have shown considerable promise. One patient, » Read More

Philadelphia Asbestos Lawyers: A New Tool in Mesothelioma Clinical Trial Selection

A group of researchers in the United Kingdom recently discovered a way to group patients in clinical trials in order to help determine success rates. In this case, the researchers were able to better predict a patient’s response to the clinical trial according to three biological factors. They are: The level of albumin in the » Read More

← Older posts Newer posts →